医学
威尼斯人
慢性淋巴细胞白血病
内科学
人口
不利影响
苯达莫司汀
肿瘤科
恶心
进行性疾病
胃肠病学
白血病
化疗
环境卫生
作者
Mazyar Shadman,Talha Munir,Shuo Ma,Masa Lasica,Monica Tani,Tadeusz Robak,Ian W. Flinn,Jennifer R. Brown,Paolo Ghia,Emmanuelle Ferrant,Constantine S. Tam,Wojciech Janowski,Wojciech Jurczak,Linlin Xu,Tian Tian,Marcus Lefebure,Stephanie Agresti,Jamie Hirata,Alessandra Tedeschi
摘要
Zanubrutinib + venetoclax demonstrated impressive efficacy and a favorable safety profile in patients with TN CLL/SLL, regardless of the presence of TP53-aberrant disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI